| [1] PubMed ID: | 32547104 |
| Disease Name: | Chordoma |
| Sample: | chordoma tissues |
| Dysfunction Pattern: | regulation[miR-124-3p/iASPP Pathway] |
| Validated Method: | CCK8//qRT-PCR//Flow Cytometry |
| Description: | We found that lncRNA XIST expression was upregulated in chordoma and strongly correlated with poor patient prognosis.Our findings demonstrate a key role for lncRNA XIST in chordoma progression by regulating miR124-3p/iAPSS pathway. |
| Causality: | Yes |
| Causal Description: | Moreover, lncRNA XIST promoted proliferation and inhibited apoptosis of chordoma cells. |
| Clinical-realted Application: | We found that lncRNA XIST expression was upregulated in chordoma and strongly correlated with poor patient prognosis. |
| [2] PubMed ID: | 35899235 |
| Disease Name: | Chordoma |
| Sample: | chordoma tissues |
| Dysfunction Pattern: | Interaction( miR-320d/ARF6) |
| Validated Method: | RNA Pull-Down//IHC//Western Blot//Transfection//qRT-PCR//Luciferase Report Assay//Cell Proliferation Assay//Colony Formation Assay//Transwell Assay |
| Description: | XIST was overexpressed in chordoma tissues. XIST acted as a sponge of miR-320d. Moreover, miR-320d overexpression inhibited the proliferation, migration, invasion, and glycolysis of chordoma cells. ARF6 was a direct target of miR-320d, and XIST upregulated ARF6 expression via sponging miR-320d. Furthermore, overexpression of ARF6 reversed the inhibitory effects of XIST knockdown on chordoma cell proliferation, migration, invasion, and glycolysis. |
| Causality: | Yes |
| Causal Description: | XIST knockdown suppressed chordoma cell proliferation, migration, invasion, and glycolysis. |
| Clinical-realted Application: | |
|